Anu Kenttämies

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Magnetic Resonance

Radical Prostatectomy

Contrast Enhanced

Prostate Cancer

Top Venues

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Cancer research communications

BJU international

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of clinically significant prostate cancer after a non-suspicious prostate MRI - a comparison with the general population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Juho Pylväläinen, Jaakko Hoffström, Anu Kenttämies, Anssi Auvinen, Tuomas K Mirtti, Antti Sakari Rannikko
Risk of Clinically Significant Prostate Cancer after a Nonsuspicious Prostate MRI-A Comparison with the General Population. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 33 (5) (2024)
Timo-Pekka K Lehto, Juho Pylväläinen, Kevin Sandeman, Anu Kenttämies, Stig Nordling, Ian G Mills, Jing Tang, Tuomas K Mirtti, Antti Sakari Rannikko
Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis. International journal of cancer (2023)
Antti Sakari Rannikko, Mare Leht, Tuomas K Mirtti, Anu Kenttämies, Teemu Tolonen, Irina Rinta-Kiikka, Tuomas P Kilpeläinen, Kari Natunen, Hans G Lilja, Terho Lehtimäki, Jani Raitanen, Paula Kujala, Johanna Ronkainen, Mika Matikainen, Anssi Petas, Kimmo Taari, Teuvo L J Tammela, Anssi Auvinen
Population-based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study. BJU international 130 (2) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti Sakari Rannikko, Tuomas K Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)
Teijo Pellinen, Kevin Sandeman, Sami Blom, Riku Turkki, Annabrita Hemmes, Katja Välimäki, Juho Eineluoto, Anu Kenttämies, Stig Nordling, Olli Kallioniemi, Antti Sakari Rannikko, Tuomas K Mirtti
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer. Cancer research communications 2 (3) (2022)